Ballentine Partners’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
KCM
Ballentine Partners's LEGN Position: Q3 2026 in Review
Ballentine Partners sold out of Legend Biotech (LEGN) in Q3 2026, closing a stake of 7,235 shares — an estimated $209K sold.
Ballentine Partners first reported a position in LEGN in Q2 2026 and held it in 1 quarter. The position peaked at $209K in Q2 2026. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.
- Ballentine Partners reported no remaining Legend Biotech position as of Q3 2026 after selling out during the quarter.
- Ballentine Partners sold 7,235 Legend Biotech shares in Q3 2026, an estimated $209K.
- Ballentine Partners first reported a position in Legend Biotech in Q2 2026 and held it in 1 quarter.
- Ballentine Partners's Legend Biotech position peaked at $209K in Q2 2026.
- 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.